Cargando…
Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment
BACKGROUND AND AIMS: This study determined the kinetics of gene expression during the first 10 weeks of therapy with Pegylated-interferon-alfa2b (PegIntron™) and ribavirin (administered by weight) in HCV patients and compared it with the recently completed Virahep C study [1,2] in which Peginterfero...
Autores principales: | Taylor, Milton W, Tsukahara, Takuma, McClintick, Jeanette N, Edenberg, Howard J, Kwo, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613871/ https://www.ncbi.nlm.nih.gov/pubmed/18986530 http://dx.doi.org/10.1186/1479-5876-6-66 |
Ejemplares similares
-
Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha/ribavirin in HCV patients blood mononuclear cells (PBMC)
por: Gupta, Rahul, et al.
Publicado: (2012) -
Effects of filtering by Present call on analysis of microarray experiments
por: McClintick, Jeanette N, et al.
Publicado: (2006) -
Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature
por: Cacopardo, Bruno, et al.
Publicado: (2013) -
Mapping of trans-acting regulatory factors from microarray data
por: McClintick, Jeanette N, et al.
Publicado: (2007) -
Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005)